Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

13.45
Delayed Data
As of Feb 24
 +0.25 / +1.89%
Today’s Change
10.52
Today|||52-Week Range
19.98
+9.62%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close13.20
Today’s open13.09
Day’s range13.04 - 13.46
Volume839,408
Average volume (3 months)1,564,886
Market cap$2.1B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-81.97%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book283.04

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...-0.54-0.89%
JUNOJuno Therapeutics In...-0.68-3.07%
RDUSRadius Health Inc-2.14-4.95%
EXASExact Sciences Corp-0.26-1.20%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts


Search for Jobs